5 Oct 2026 09:00
Changes in Testosterone Therapy
Testosterone therapy remains a frequently discussed and often controversial topic in patient care. This course reviews current perspectives on testosterone therapy, including potential benefits, safety considerations, monitoring recommendations, and areas of ongoing debate. You will be better prepared to interpret the evidence and support the safe and appropriate use of testosterone therapy in clinical practice.HOSTRachel Maynard, PharmDGameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpactGUESTMichael Nagy, PharmDClinical Pharmacy PractitionerTomah VAMC
GET CE FOR LISTENING!Stay Compliant. Grow Clinically. Practice with Confidence.
Purchase a CE Subscription to get CE credit for this episode.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update are included with a Pharmacist or Technician CE Subscription. But wait…there’s even more!
The Pharmacist & Technician CE Subscriptions include: - Compliance and licensure CE - GameChangers Clinical Updates- Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
CEimpact's CE Subscriptions: All your CE in one convenient subscription. Purchase Now!
PRACTICE RESOURCEReceive the exclusive Practice Resource to use as a reference guide for this episode by purchasing a Pharmacist or Technician CE Subscription.
CPE REDEMPTIONThis course is accredited for continuing pharmacy education!
If you have a CE Subscription and are ready to claim credit, click the link below for your practice role:
If you do not have a CE Subscription, click here to purchase and claim credit for this episode!
CPE INFORMATIONLearning ObjectivesUpon successful completion of this knowledge-based activity, participants should be able to:1. Describe current indications, potential benefits, and safety considerations associated with testosterone therapy.2. Identify evidence-based considerations for patient selection, monitoring, and safe use of testosterone therapy.
Rachel Maynard and Michael Nagey have no relevant financial relationships to disclose.0.075 CEU/0.75 HrUAN: 0107-0000-26-339-H01-P Initial release date: 10/5/2026Expiration date: 10/5/2029Additional CPE details can be found here for pharmacists and here for pharmacy technicians.
